课题基金 / 基金详情

LAT: Low temperature Ambient pressure Technology fo wastewater treatment

LAT: Low temperature Ambient pressure Technology fo wastewater treatment
LAT:低温常压废水处理技术
批准号:
104011
负责人:
金额:
$44.4万
依托单位:
依托单位国家:
英国
项目类别:
Collaborative R&D
财政年份:
2018
资助国家:
英国
项目状态:
已结题
起止时间:
2018 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Rapid economic development and urbanization have led to rising water consumption and rampant pollution in China. The Chinese government’s 13th Five-Year Plan includes objectives to enhance environmental protection, emphasizing rigorous control of pollutant discharge and mandates water reuse and recycling in new and existing coal-fired power plants and coal-to-chemical refining facilities for treating complex industrial process waste streams. These “challenges” represent business opportunities for UK-based Solaquagen International (SQG), and a niche for deploying SQG’s awards winning innovative low temperature, ambient pressure, humidification-dehumidification technology, “LAT”. The project objective is to deploy LAT to “cleaning” highly variable wastewaters, that are typical of Landfill Leachate and Coal Chemical plants in China. The project is a partnership between SQG and Denovo (Shanghai, China), aimed at proving industrial research on a LAT pilot at a Shanghai site. The ability of LAT to address the challenges will contribute towards climate action, resource efficiency and raw materials issues facing the world. The impact on SQG as a business will be significant with sustained credibility as a leader of “green” water treatment technology and a return of £7.5 per £1 invested is expected, 2 years after the completion of the project.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
骨髓微环境中正常造血干/祖细胞新亚群IL7Rα(-)LSK(low)细胞延缓急性髓系白血病进程的作用及机制研究
MSCEN聚集体抑制CD127low单核细胞铜死亡治疗SLE 的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    耿林玉
  • 依托单位:
新型PDL1+CXCR2low中性粒细胞在脉络膜新生血管中的作用及机制研究
  • 批准号:
    82271095
  • 项目类别:
    面上项目
  • 资助金额:
    56万元
  • 批准年份:
    2022
  • 负责人:
    柳夏林
  • 依托单位:
CD9+CD55low脂肪前体细胞介导高脂诱导脂肪组织炎症和2型糖尿病的作用和机制研究
  • 批准号:
    82270883
  • 项目类别:
    面上项目
  • 资助金额:
    52万元
  • 批准年份:
    2022
  • 负责人:
    毕艳
  • 依托单位: